Also trades as: CARERATING.NS (NSE) · $vol 1M
CARERATING.BO BSE
CARE Ratings Limited
1W: -0.6%
1M: -5.9%
3M: -2.4%
YTD: -0.6%
1Y: -3.1%
3Y: +123.6%
5Y: +126.3%
₹1,598.45 ($16.60)
-6.40 (-0.40%)
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
Income Trends
Revenue
$4.7B
+17.6% ▲
5Y CAGR: +14.6%
Gross Profit
$2.4B
+4.9% ▲
5Y CAGR: +12.8%
Operating Income
$1.9B
+29.0% ▲
5Y CAGR: +15.0%
Net Income
$1.7B
+24.7% ▲
5Y CAGR: +13.8%
EPS (Diluted)
$17.51
-61.7% ▼
5Y CAGR: -10.4%
EBITDA
$2.0B
-2.6% ▼
5Y CAGR: +9.5%
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
| Revenue | $2.5B | $2.8B | $3.3B | $4.0B | $4.7B |
| YoY Growth | +3.3% | +13.0% | +18.9% | +21.3% | +17.6% |
| Cost of Revenue | $1.1B | $1.2B | $1.8B | $1.7B | $2.3B |
| Gross Profit | $1.3B | $1.5B | $1.5B | $2.3B | $2.4B |
| Gross Margin | 54.6% | 55.5% | 44.8% | 56.8% | 50.7% |
| R&D Expenses | $0 | $0 | $17M | $0 | $8M |
| SG&A Expenses | $109M | $118M | $154M | $179M | $197M |
| Operating Expenses | $623M | $602M | $447M | $842M | $534M |
| Operating Income | $725M | $946M | $1.0B | $1.4B | $1.9B |
| Operating Margin | 29.4% | 33.9% | 31.3% | 35.9% | 39.4% |
| Interest Expense | $5M | $10M | $17M | $21M | $25M |
| Income Before Tax | $986M | $1.3B | $1.5B | $1.9B | $2.4B |
| Tax Expense | $218M | $403M | $441M | $523M | $617M |
| Net Income | $751M | $835M | $1.0B | $1.4B | $1.7B |
| Net Margin | 30.4% | 29.9% | 30.3% | 34.1% | 36.2% |
| EPS (Diluted) | $25.31 | $28.17 | $33.67 | $45.69 | $17.51 |
| EBITDA | $1.1B | $1.4B | $1.6B | $2.1B | $2.0B |
| Shares Outstanding | 30M | 30M | 30M | 30M | 98M |